The Effect of Semiconductor Knee Sleeves on Pain in Osteoarthritis of the Knee.

NCT ID: NCT05255835

Last Updated: 2023-09-25

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Clinical Phase

NA

Total Enrollment

50 participants

Study Classification

INTERVENTIONAL

Study Start Date

2022-11-30

Study Completion Date

2026-01-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

To assess the benefits of using semiconductor (germanium and carbon) woven knee sleeves products in patients with osteoarthritis of the knee. To compare patients in a blinded randomized trial with and without the semiconductor knee sleeves product during the first 3 months period after initial contact at the outpatient clinic.

Aims:

The hypothesis of the study is that the semiconductor sleeve will reduce pain and improve knee function in active group when compared to the placebo group.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Semiconductor woven knee sleeves work by increasing circulation to reduce inflammation, relieve pain, optimize performance, and accelerate recovery. Unlike compression products, semiconductor knee sleeves do not need to compress to work. Instead, the technology incorporates the semiconductor elements germanium and carbon within the fabric, which when stimulated by body heat, by release of negative ions. The negative ions activate molecular vibrations that increase blood flow and speed. Increasing circulation helps bring more oxygen and nutrients to the target area, which optimizes the body's natural healing process and accelerates recovery. Benefits of Increased Blood Circulation Include:

* Accelerated Recovery
* Reduced Swelling
* Optimized Performance
* Reduced Fatigue
* Thermoregulation

Investigators wish to investigate a possible effect on knee pain and function in patients with osteoarthritis of the knee.

Subject Enrollment:

Subjects referred with arthrosis of the knee to the out-patient clinic, at the Hip- and Knee-arthroplasty Unit, Herlev Gentofte Hospital. Included subjects must be assessed by an arthroplasty surgeon to have arthrosis without present indication for surgery, and to be eligible for a period of conservative treatment including physiotherapist guided training and paracetamol treatment.

This is a prospective study that will require informed consent.

Study size calculation A 25% difference in pain reduction between the intervention group compared and the placebo group is considered clinically relevant. Standard deviation expected at 25 mm on a 100 mm visual analog scale (VAS) for pain1. A type II error set at 10%, and a two-sided 5% significance level. A total number of 36 subjects with 18 in each group was calculated. To account for dropouts and the risk of conversion to surgical strategy during the follow-up period we plan to enroll a total of 25 subjects in each group.

Study Population: Estimated enrollment Target enrollment - 50 patients

* 25 patients with the semiconductor knee sleeve.
* 25 patients with the placebo sleeve.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Osteo Arthritis Knee

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Randomized controlled trial (RCT)
Primary Study Purpose

TREATMENT

Blinding Strategy

TRIPLE

Participants Caregivers Outcome Assessors
Investigated knee sleeves appear identical, a printed code reveals to investigator if knee sleeves contains semiconductors (intervention group) or are cotton only (placebo group).

Participants, care provider and outcome assessors are blinded to intervention/placebo grouping.

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Semiconductor knee-sleeves

Knee-sleeves containing semiconductor elements within the fabric constitute the intervention arm.

Group Type ACTIVE_COMPARATOR

Semiconductor Knee Sleeves

Intervention Type DEVICE

semiconductor elements germanium and carbon within the cotton fabric

Placebo knee-sleeves

Cotton knee-sleeves constitute the placebo arm.

Group Type PLACEBO_COMPARATOR

Cotton Knee Sleeves (Placebo)

Intervention Type DEVICE

cotton fabric knee sleeves

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Semiconductor Knee Sleeves

semiconductor elements germanium and carbon within the cotton fabric

Intervention Type DEVICE

Cotton Knee Sleeves (Placebo)

cotton fabric knee sleeves

Intervention Type DEVICE

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

Incrediwear Incrediwear (Placebo)

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Arthrosis of the Knee
* Surgery not yet indicated
* 40-90 years old
* Male or female
* Compliant patient
* BMI less than 35
* Able to understand Danish sufficiently for written consent

Exclusion Criteria

* Rheumatoid Arthritis
* Previous blood clots
* BMI greater than 35
* Varicosities on operative leg
Maximum Eligible Age

90 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Herlev and Gentofte Hospital

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Mikkel Rathsach Andersen

MD., Ph.D., Associate prof.

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Mikkel R Andersen, MD., Ph.D.

Role: STUDY_CHAIR

Gentofte Hospital

Mathias R Vergmann, Physiotherapeut

Role: PRINCIPAL_INVESTIGATOR

Gentofte Hospital

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Gentofte Hospital

Copenhagen, , Denmark

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Denmark

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Mikkel R Andersen, MD, Ph.D.

Role: CONTACT

+4538672796

Mathias R Vergmann, Physiotherapuet

Role: CONTACT

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Mikkel R Andersen, MD, Ph.D.

Role: primary

+4538672796

Mathias R Vergmann

Role: backup

+4538677456

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

H-20080028

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Epidemiology and Nutrition
NCT05546541 UNKNOWN
A Trial of SB-061 in Osteoarthritis of the Knee
NCT02802709 COMPLETED PHASE1/PHASE2